Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience, Vivlion Partner on Guide RNA Libraries for CRISPR Applications

NEW YORK – Twist Bioscience said on Wednesday it is partnering with Vivlion to generate guide RNA, or gRNA, libraries for use in CRISPR studies.

Under the terms of the deal, Vivlion will purchase Twist's oligo pools to generate and sell precision CRISPR libraries for functional genomics research. Vivlion's proprietary 3Cs technology bypasses standard cloning methods such as PCR amplification, allowing direct conversion of Twist's oligo pools into gRNA libraries that maintain uniformity, including the generation of multiplexed and fixed-pair libraries.

"Twist is the ideal partner for the oligos needed for our CRISPR libraries. Their market expertise and ability to quickly generate large quantities of long, high-quality oligonucleotides provides Vivlion with a ready-made platform to amplify our impact," Vivlion CEO Ivan Dikic said in a statement. "The combined technologies have the potential to accelerate genomic research and enable scientists to decipher the function of genes more quickly."

Germany-based Vivlion is a spinout from Goethe University Frankfurt am Main offering gene editing reagents and screening services for the global R&D market.

In December 2020, Vivlion obtained a non-exclusive license to ERS Genomics' CRISPR-Cas9 patent portfolio.


The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.